J&J drug offers hope in advanced prostate cancer

J&J drug offers hope in advanced prostate cancer: "MILAN (Reuters) - Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

"